Northern Trust Portfolio holdings
Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$431M |
| 2 |
Truist Financial
TFC
|
+$346M |
| 3 |
Alibaba
BABA
|
+$238M |
| 4 |
ServiceNow
NOW
|
+$228M |
| 5 |
Corteva
CTVA
|
+$156M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$875M |
| 2 |
FlexShares Global Upstream Natural Resources Index Fund
GUNR
|
+$395M |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$340M |
| 4 |
Oracle
ORCL
|
+$197M |
| 5 |
Apple
AAPL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.13% |
| 2 | Financials | 14.48% |
| 3 | Healthcare | 12.77% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3226
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$32.6B
| $1.65M | ﹤0.01% |
1,220,639
+145,768
| +14% | +$18.6M |
|
|
GRP.U
3227
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $1.64M | ﹤0.01% |
32,352
+2,425
| +8% | +$122K |
|
3228
Kiniksa Pharmaceuticals
KNSA
$6.07B
| $1.64M | ﹤0.01% |
148,208
-15,305
| -9% | -$133K |
|
|
UBFO
3229
DELISTED
United Security Bancshares
UBFO
| $1.64M | ﹤0.01% |
152,742
+9,579
| +7% | +$99.6K |
|
3230
Bain Capital Specialty
BCSF
$833M
| $1.63M | ﹤0.01% |
84,147
+71,979
| +592% | +$1.35M |
|
|
APLT
3231
DELISTED
Applied Therapeutics
APLT
| $1.63M | ﹤0.01% |
59,656
+36,438
| +157% | +$624K |
|
|
PRTK
3232
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $1.61M | ﹤0.01% |
398,800
-27,589
| -6% | -$95.7K |
|
|
GEN
3233
DELISTED
Genesis Healthcare, Inc.
GEN
| $1.6M | ﹤0.01% |
978,663
+39,002
| +4% | +$58.6K |
|
|
OYST
3234
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $1.6M | ﹤0.01% |
+65,554
| New | +$1.15M |
|
3235
Celsius Holdings
CELH
$7.11B
| $1.6M | ﹤0.01% |
993,309
+117,660
| +13% | +$156K |
|
|
CBAY
3236
DELISTED
Cymabay Therapeutics
CBAY
| $1.6M | ﹤0.01% |
815,190
-19,683
| -2% | -$73.9K |
|
3237
Seres Therapeutics
MCRB
$46.6M
| $1.59M | ﹤0.01% |
23,006
-765
| -3% | -$56.7K |
|
|
AXIA.PR
3238
DELISTED
AXIA Energia American Depositary Shares Preferred Class B1
AXIA.PR
| $1.58M | ﹤0.01% |
211,120
-3,282
| -2% | -$23.9K |
|
3239
Union Bankshares
UNB
$120M
| $1.58M | ﹤0.01% |
43,696
-651
| -1% | -$22.2K |
|
3240
Marchex
MCHX
$77.1M
| $1.58M | ﹤0.01% |
418,630
-15,720
| -4% | -$56.5K |
|
|
NBEV
3241
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $1.58M | ﹤0.01% |
868,169
-1,653
| -0.2% | -$3.91K |
|
3242
Global Water Resources
GWRS
$219M
| $1.57M | ﹤0.01% |
119,799
-2,214
| -2% | -$27.8K |
|
3243
Biglari Holdings Class B
BH
$1.2B
| $1.56M | ﹤0.01% |
13,679
-167
| -1% | -$17K |
|
|
VRN
3244
DELISTED
Veren
VRN
| $1.56M | ﹤0.01% |
348,567
-3,539
| -1% | -$13.8K |
|
|
SRT
3245
DELISTED
Startek Inc.
SRT
| $1.55M | ﹤0.01% |
193,961
+14,614
| +8% | +$107K |
|
|
AKRO
3246
DELISTED
Akero Therapeutics
AKRO
| $1.53M | ﹤0.01% |
69,161
-775
| -1% | -$16K |
|
|
CSLT
3247
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $1.53M | ﹤0.01% |
1,152,435
-179,177
| -13% | -$250K |
|
3248
BlueLinx
BXC
$706M
| $1.53M | ﹤0.01% |
107,312
-314
| -0.3% | -$6.44K |
|
3249
BlackBerry
BB
$5.26B
| $1.52M | ﹤0.01% |
237,483
+32,016
| +16% | +$176K |
|
3250
FirstService
FSV
$6.3B
| $1.52M | ﹤0.01% |
16,395
-47
| -0.3% | -$4.43K |
|
Similar funds
Northern Trust's Q4 2019 Portfolio in Review
As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
- Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
- Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
- Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
- Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
- Northern Trust opened 134 new positions and closed 124 in Q4 2019.
- Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.
Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.